Asset Management One’s Medifast MED Stock Holding History

Asset Management One’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-8,438	Closed	-$1.63M	–	1070
2021 Q3	$1.63M	Buy	8,438 +1,401	+20%	+$344K	0.01%	820
2021 Q2	$1.99M	Buy	+7,037	New	+$1.91M	0.01%	810
2015 Q2	–	Sell	-6,998	Closed	-$210K	–	1378
2015 Q1	$210K	Buy	+6,998	New	+$222K	﹤0.01%	1249

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Asset Management One's MED Position: Q4 2021 in Review

Asset Management One sold out of Medifast (MED) in Q4 2021, closing a stake of 8,438 shares — an estimated $1.63M sold.

Asset Management One first reported a position in MED in Q1 2015 and held it in 3 quarters. The position peaked at $1.99M in Q2 2021. 297 funds tracked by Wall St. Rank hold MED as of Q4 2021.

Asset Management One reported no remaining Medifast position as of Q4 2021 after selling out during the quarter.
Asset Management One sold 8,438 Medifast shares in Q4 2021, an estimated $1.63M.
Asset Management One first reported a position in Medifast in Q1 2015 and held it in 3 quarters.
Asset Management One's Medifast position peaked at $1.99M in Q2 2021.
297 funds tracked by Wall St. Rank held Medifast as of Q4 2021.

Based on Asset Management One's 13F filing for Q4 2021, filed 9 Feb 2022.